205 related articles for article (PubMed ID: 11697649)
1. Survey of early disapearance of BCR/ABL fusion transcript after allogeneic or autologous stem cell transplantation for chronic myelogenous leukemia.
Vey N; Balatzentko G; Lafage M; Sainty D; Bouabdallah R; Chabannon C; Blaise D; Gastaut JA; Gabert J
Leuk Lymphoma; 2001; 42(5):945-52. PubMed ID: 11697649
[TBL] [Abstract][Full Text] [Related]
2. Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia.
Olavarria E; Kanfer E; Szydlo R; Kaeda J; Rezvani K; Cwynarski K; Pocock C; Dazzi F; Craddock C; Apperley JF; Cross NC; Goldman JM
Blood; 2001 Mar; 97(6):1560-5. PubMed ID: 11238091
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantation.
Eder M; Battmer K; Kafert S; Stucki A; Ganser A; Hertenstein B
Leukemia; 1999 Sep; 13(9):1383-9. PubMed ID: 10482989
[TBL] [Abstract][Full Text] [Related]
4. Quantitative real-time reverse-transcription polymerase chain reaction for diagnosis of BCR-ABL positive leukemias and molecular monitoring following allogeneic stem cell transplantation.
Neumann F; Herold C; Hildebrandt B; Kobbe G; Aivado M; Rong A; Free M; Rössig R; Fenk R; Schneider P; Gattermann N; Royer-Pokora B; Haas R; Kronenwett R
Eur J Haematol; 2003 Jan; 70(1):1-10. PubMed ID: 12631253
[TBL] [Abstract][Full Text] [Related]
5. Early prediction of molecular remission by monitoring BCR-ABL transcript levels in patients achieving a complete cytogenetic response after imatinib therapy for posttransplantation chronic myelogenous leukemia relapse.
Kim YJ; Kim DW; Lee S; Min CK; Goh HG; Kim SH; Lee JY; Kim YL; Kim HJ; Kim HJ; Lee JW; Kim TG; Min WS; Kim CC
Biol Blood Marrow Transplant; 2004 Oct; 10(10):718-25. PubMed ID: 15389438
[TBL] [Abstract][Full Text] [Related]
6. Prediction of relapse by day 100 BCR-ABL quantification after allogeneic stem cell transplantation for chronic myeloid leukemia.
Asnafi V; Rubio MT; Delabesse E; Villar E; Davi F; Damaj G; Hirsch I; Dhédin N; Vernant JP; Varet B; Buzyn A; Macintyre E
Leukemia; 2006 May; 20(5):793-9. PubMed ID: 16541140
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210(BCR-ABL) and p190(BCR-ABL) after allogeneic bone marrow transplantation for chronic myeloid leukemia: increasing mixed myeloid chimerism and p190(BCR-ABL) detection precede cytogenetic relapse.
Serrano J; Roman J; Sanchez J; Jimenez A; Castillejo JA; Herrera C; Gonzalez MG; Reina L; Rodriguez MC; Alvarez MA; Maldonado J; Torres A
Blood; 2000 Apr; 95(8):2659-65. PubMed ID: 10753848
[TBL] [Abstract][Full Text] [Related]
8. Molecular monitoring of BCR-ABL transcripts after allogeneic stem cell transplantation for chronic myeloid leukemia.
Arpinati M; Tolomelli G; Bochicchio MT; Castagnetti F; Amabile M; Bandini G; Bonifazi F; Stanzani M; Rosti G; Martinelli G; Baccarani M
Biol Blood Marrow Transplant; 2013 May; 19(5):735-40. PubMed ID: 23333776
[TBL] [Abstract][Full Text] [Related]
9. BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning.
Lange T; Deininger M; Brand R; Hegenbart U; Al-Ali H; Krahl R; Poenisch W; Uharek L; Leiblein S; Gentilini C; Petersdorf E; Storb RF; Niederwieser D
Leukemia; 2004 Sep; 18(9):1468-75. PubMed ID: 15241437
[TBL] [Abstract][Full Text] [Related]
10. Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia.
Hessner MJ; Endean DJ; Casper JT; Horowitz MM; Keever-Taylor CA; Roth M; Flomenberg N; Drobyski WR
Blood; 1995 Nov; 86(10):3987-96. PubMed ID: 7579370
[TBL] [Abstract][Full Text] [Related]
11. Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation.
Zhang JG; Lin F; Chase A; Goldman JM; Cross NC
Blood; 1996 Mar; 87(6):2588-93. PubMed ID: 8630427
[TBL] [Abstract][Full Text] [Related]
12. Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term Post-Allogeneic Stem Cell Transplantation Chronic Myeloid Leukemia Patients.
Koren-Michowitz M; Shimoni A; Daraio F; Crasto F; Lorenzatti R; Volchek Y; Amariglio N; Gottardi E; Saglio G; Nagler A
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1852-5. PubMed ID: 26151304
[TBL] [Abstract][Full Text] [Related]
13. [Follow-up detection of M-bcr/abl and m-bcr/abl fusion transcripts in chronic myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation].
Qin YZ; Liu YR; Li JL; Fu JY; Chang Y; Ruan GR; Wang H; Qiu JY; Lu DP; Chen SS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Aug; 11(4):368-71. PubMed ID: 12962564
[TBL] [Abstract][Full Text] [Related]
14. Poor correlation of kinetics between BCR-ABL and WT1 transcript levels after allogeneic stem cell transplantation.
Uzunel M; Ringdén O
Bone Marrow Transplant; 2004 Jan; 33(1):47-52. PubMed ID: 14704656
[TBL] [Abstract][Full Text] [Related]
15. Frequent detection of BCR-ABL specific mRNA in patients with chronic myeloid leukemia (CML) following allogeneic and syngeneic bone marrow transplantation (BMT).
Gaiger A; Lion T; Kalhs P; Mitterbauer G; Henn T; Haas O; Födinger M; Kier P; Forstinger C; Quehenberger P
Leukemia; 1993 Nov; 7(11):1766-72. PubMed ID: 8231244
[TBL] [Abstract][Full Text] [Related]
16. Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients.
Radich JP; Gehly G; Gooley T; Bryant E; Clift RA; Collins S; Edmands S; Kirk J; Lee A; Kessler P
Blood; 1995 May; 85(9):2632-8. PubMed ID: 7727789
[TBL] [Abstract][Full Text] [Related]
17. [Dynamic detection of chimerism and fusion gene in chronic myeloid leukemia patients relapsed after allogeneic hematopoietic stem cell transplantation].
Sun JF; Zhao DD; Han XP; Jin HS; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):833-7. PubMed ID: 18718071
[TBL] [Abstract][Full Text] [Related]
18. Quantitative competitive reverse transcriptase-polymerase chain reaction for BCR-ABL on Philadelphia-negative leukaphereses allows the selection of low-contaminated peripheral blood progenitor cells for autografting in chronic myelogenous leukemia.
Corsetti MT; Lerma E; Dejana A; Basta P; Ferrara R; Benvenuto F; Vassallo F; Abate M; Piaggio G; Parodi C; Sessarego M; Li Pira G; Manca F; Carella AM
Leukemia; 1999 Jul; 13(7):999-1008. PubMed ID: 10400414
[TBL] [Abstract][Full Text] [Related]
19. Detection of BCR/ABL RNA transcripts using the polymerase chain reaction is highly predictive for relapse in patients transplanted with unrelated marrow grafts for chronic myelogenous leukaemia.
Drobyski WR; Endean DJ; Klein JP; Hessner MJ
Br J Haematol; 1997 Aug; 98(2):458-66. PubMed ID: 9266951
[TBL] [Abstract][Full Text] [Related]
20. [Significance of quantitative detection of bcr-abl mRNA in chronic myeloid leukemia patients after allogeneic hematopoietic stem cell transplant].
Geng SX; DU X; Weng JY; Li QH; Su JH; Lin QX; Li YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):993-7. PubMed ID: 17956677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
